BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38154741)

  • 1. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    Capelli N; Marion O; Dubois M; Allart S; Bertrand-Michel J; Lhomme S; Abravanel F; Izopet J; Chapuy-Regaud S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.
    Nagashima S; Takahashi M; Kobayashi T; ; Nishizawa T; Nishiyama T; Primadharsini PP; Okamoto H
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E.
    Al-Ayoubi J; Behrendt P; Bremer B; Suneetha PV; Gisa A; Rinker F; Manns MP; Cornberg M; Wedemeyer H; Kraft ARM
    Liver Int; 2018 Feb; 38(2):266-277. PubMed ID: 28718943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.
    Aggarwal R; Shukla R; Jameel S; Agrawal S; Puri P; Gupta VK; Patil AP; Naik S
    J Viral Hepat; 2007 Apr; 14(4):283-92. PubMed ID: 17381721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.
    Bremer W; Blasczyk H; Yin X; Salinas E; Grakoui A; Feng Z; Walker C
    J Hepatol; 2021 Sep; 75(3):557-564. PubMed ID: 33961939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
    Suneetha PV; Pischke S; Schlaphoff V; Grabowski J; Fytili P; Gronert A; Bremer B; Markova A; Jaroszewicz J; Bara C; Manns MP; Cornberg M; Wedemeyer H
    Hepatology; 2012 Mar; 55(3):695-708. PubMed ID: 22006345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocytic recycling compartment serves as a viral factory for hepatitis E virus.
    Bentaleb C; Hervouet K; Montpellier C; Camuzet C; Ferrié M; Burlaud-Gaillard J; Bressanelli S; Metzger K; Werkmeister E; Ankavay M; Janampa NL; Marlet J; Roux J; Deffaud C; Goffard A; Rouillé Y; Dubuisson J; Roingeard P; Aliouat-Denis CM; Cocquerel L
    Cell Mol Life Sci; 2022 Dec; 79(12):615. PubMed ID: 36460928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E virus (HEV) open reading frame 2: Role in pathogenesis and diagnosis in HEV infections.
    Sayed IM; Karam-Allah Ramadan H; Hafez MHR; Elkhawaga AA; El-Mokhtar MA
    Rev Med Virol; 2022 Nov; 32(6):e2401. PubMed ID: 36209386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses.
    Yin X; Ambardekar C; Lu Y; Feng Z
    J Virol; 2016 Apr; 90(8):4232-4242. PubMed ID: 26865708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
    Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
    J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Montpellier C; Wychowski C; Sayed IM; Meunier JC; Saliou JM; Ankavay M; Bull A; Pillez A; Abravanel F; Helle F; Brochot E; Drobecq H; Farhat R; Aliouat-Denis CM; Haddad JG; Izopet J; Meuleman P; Goffard A; Dubuisson J; Cocquerel L
    Gastroenterology; 2018 Jan; 154(1):211-223.e8. PubMed ID: 28958858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and Memory B Cell Responses in Hepatitis E Recovered Individuals, 1-30 Years Post Hepatitis E Virus Infection.
    Kulkarni SP; Sharma M; Tripathy AS
    Sci Rep; 2019 Mar; 9(1):4090. PubMed ID: 30858463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
    Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
    Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.